Cambridge Investment Research Advisors’s Charles River Laboratories CRL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $236K | Sell |
1,554
-372
| -19% | -$56.5K | ﹤0.01% | 3188 |
|
|
2025
Q1 | $290K | Buy |
1,926
+123
| +7% | +$18.5K | ﹤0.01% | 2892 |
|
|
2024
Q4 | $333K | Sell |
1,803
-175
| -9% | -$32.3K | ﹤0.01% | 2756 |
|
|
2024
Q3 | $390K | Buy |
1,978
+93
| +5% | +$18.3K | ﹤0.01% | 2615 |
|
|
2024
Q2 | $389K | Buy |
1,885
+158
| +9% | +$32.6K | ﹤0.01% | 2497 |
|
|
2024
Q1 | $468K | Buy |
1,727
+206
| +14% | +$55.8K | ﹤0.01% | 2330 |
|
|
2023
Q4 | $360K | Sell |
1,521
-197
| -11% | -$46.6K | ﹤0.01% | 2460 |
|
|
2023
Q3 | $337K | Sell |
1,718
-41
| -2% | -$8.04K | ﹤0.01% | 2415 |
|
|
2023
Q2 | $370K | Buy |
1,759
+414
| +31% | +$87.1K | ﹤0.01% | 2364 |
|
|
2023
Q1 | $271K | Sell |
1,345
-5,610
| -81% | -$1.13M | ﹤0.01% | 2574 |
|
|
2022
Q4 | $1.52M | Buy |
6,955
+215
| +3% | +$46.8K | 0.01% | 1252 |
|
|
2022
Q3 | $1.33M | Buy |
6,740
+5,181
| +332% | +$1.02M | 0.01% | 1288 |
|
|
2022
Q2 | $334K | Sell |
1,559
-35
| -2% | -$7.5K | ﹤0.01% | 2286 |
|
|
2022
Q1 | $453K | Sell |
1,594
-4,432
| -74% | -$1.26M | ﹤0.01% | 2189 |
|
|
2021
Q4 | $2.27M | Sell |
6,026
-238
| -4% | -$89.7K | 0.01% | 1069 |
|
|
2021
Q3 | $2.59M | Buy |
6,264
+2,718
| +77% | +$1.12M | 0.01% | 957 |
|
|
2021
Q2 | $1.31M | Buy |
3,546
+1,447
| +69% | +$535K | 0.01% | 1352 |
|
|
2021
Q1 | $608K | Sell |
2,099
-199
| -9% | -$57.6K | ﹤0.01% | 1758 |
|
|
2020
Q4 | $574K | Buy |
2,298
+691
| +43% | +$173K | ﹤0.01% | 1684 |
|
|
2020
Q3 | $364K | Buy |
+1,607
| New | +$364K | ﹤0.01% | 1803 |
|
|
2019
Q1 | – | Sell |
-9,422
| Closed | -$1.07M | – | 2293 |
|
|
2018
Q4 | $1.07M | Sell |
9,422
-100
| -1% | -$11.3K | 0.01% | 901 |
|
|
2018
Q3 | $1.28M | Buy |
+9,522
| New | +$1.28M | 0.01% | 893 |
|